Literature DB >> 7777725

Renovascular hypertension.

C V Ram1, G P Clagett, L R Radford.   

Abstract

Renovascular hypertension is one of the more common causes of secondary hypertension. The true prevalence of this condition is not known, because only a selected few with hypertension are considered for thorough diagnostic work-up. The higher incidence figures come from centers with a special interest in this disease. The ability of a clinician to detect renovascular hypertension has improved substantially, thanks to the advances in radiology. The predominant mechanism of blood pressure elevation from renal ischemia is activation of the renin-angiotensin system. Clinically, the pathological lesions that cause renal artery stenosis are atherosclerosis and fibromuscular dysplasia; the former is typically seen in older men, and the latter is typically found in young women. Suspicion of the presence of renovascular disease should prompt the physician to obtain appropriate screening and confirmatory tests. Once diagnosed, the management of patients with renovascular hypertension requires a carefully planned multidisciplinary approach to offer the patient a best possible therapeutic option, with surgical revascularization or balloon angioplasty, or chronic medical therapy. However, these options are not mutually exclusive. The best long-term results are obtained with surgical therapy. Although balloon angioplasty is being increasingly used perhaps as the preferred initial therapeutic procedure for many patients with renal artery stenosis, long-term results comparable with surgery are not yet available. The ideal rational therapy for patients with renal artery stenosis is reperfusion of the ischemic kidney either by surgical correction or by balloon dilation. The aim is not only to improve the blood pressure control, but also to prevent and at times to reverse renal failure. Although effective antihypertensive drugs have become available, the role of medical management of renovascular hypertension is shrinking and should be limited to patients who have contraindications to or unwilling to undergo corrective procedures to relieve renal ischemia.

Entities:  

Mesh:

Year:  1995        PMID: 7777725

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  3 in total

Review 1.  Atherosclerotic renal artery stenosis: from diagnosis to treatment.

Authors:  P Carmichael; A R Carmichael
Journal:  Postgrad Med J       Date:  1999-09       Impact factor: 2.401

2.  Fibromuscular dysplasia of the renal arteries.

Authors:  A Z Fenves; C V Ram
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

3.  Elastin haploinsufficiency induces alternative aging processes in the aorta.

Authors:  Mylène Pezet; Marie-Paule Jacob; Brigitte Escoubet; Dealba Gheduzzi; Emmanuelle Tillet; Pascale Perret; Philippe Huber; Daniela Quaglino; Roger Vranckx; Dean Y Li; Barry Starcher; Walter A Boyle; Robert P Mecham; Gilles Faury
Journal:  Rejuvenation Res       Date:  2008-02       Impact factor: 4.663

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.